Kathleen Sullivan to Antibodies, Monoclonal
This is a "connection" page, showing publications Kathleen Sullivan has written about Antibodies, Monoclonal.
Connection Strength
0.337
-
Schuelke MR, Bassiri H, Behrens EM, Canna S, Croy C, DiNofia A, Gollomp K, Grupp S, Lambert M, Lambrix A, Maude SL, Myers R, Newman H, Petrosa W, Seif A, Sullivan KE, Teachey DT, Diorio C. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023 09 26; 7(18):5603-5607.
Score: 0.203
-
Cunningham-Rundles C, Routes JM, Hostoffer R, Sullivan KE. Uncommon conundrum in common variable immunodeficiency. Clin Immunol. 2005 Sep; 116(3):208-10.
Score: 0.058
-
Triebwasser MP, Barrett DM, Bassiri H, Bunin N, Elgarten C, Freedman J, Geera AS, Monos D, Lambert MP, Olson T, Seif AE, Paessler M, Petrosa W, Reilly AF, Romberg N, Sullivan KE, Quinn GZ, Behrens E, Teachey DT. Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective. Pediatr Blood Cancer. 2021 07; 68(7):e29026.
Score: 0.043
-
Dunn K, Pasternak B, Kelsen JR, Sullivan KE, Dawany N, Wright BL. Mevalonate kinase deficiency presenting as recurrent rectal abscesses and perianal fistulae. Ann Allergy Asthma Immunol. 2018 02; 120(2):214-215.
Score: 0.034